Cocconi; Daniela

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cocconi; Daniela.The latest application filed is for "process for providing particles with reduced electrostatic charges".

Company Profile

2.12.18

Cocconi; Daniela - Parma IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation Grant 10,946,029 - Monari , et al. March 16, 2	2021-03-16
Process For Providing Particles With Reduced Electrostatic Charges App 20190216731 - Cocconi; Daniela ; et al.	2019-07-18
Dry Powder Formulation Comprising A Corticosteroid And A Beta-adrenergic For Administration By Inhalation App 20180296573 - MONARI; Elisa ; et al.	2018-10-18
Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation Grant 10,028,964 - Monari , et al. July 24, 2	2018-07-24
Use Of Magnesium Stearate In Dry Powder Formulations For Inhalation App 20180133161 - COCCONI; Daniela ; et al.	2018-05-17
Process For Preparing Carrier Particles For Dry Powders For Inhalation App 20160354314 - MUSA; Rossella ; et al.	2016-12-08
Process for preparing carrier particles for dry powders for inhalation Grant 9,445,999 - Musa , et al. September 20, 2	2016-09-20
Dry powder formulation comprising a phosphodiesterase inhibitor Grant 9,308,200 - Cocconi , et al. April 12, 2	2016-04-12
Dry Powder Formulation Comprising A Phosphodiesterase Inhibitor App 20150342936 - COCCONI; Daniela ; et al.	2015-12-03
Use Of Magnesium Stearate In Dry Powder Formulations For Inhalation App 20150320691 - COCCONI; Daniela ; et al.	2015-11-12
Dry powder formulation comprising a phosphodiesterase inhibitor Grant 9,132,121 - Cocconi , et al. September 15, 2	2015-09-15
Process For Preparing Carrier Particles For Dry Powders For Inhalation App 20150202159 - MUSA; Rossella ; et al.	2015-07-23
Dry Powder Formulation Comprising A Corticosteroid And A Beta-adrenergic For Administration By Inhalation App 20150164915 - Monari; Elisa ; et al.	2015-06-18
Process for preparing carrier particles for dry powders for inhalation Grant 8,974,831 - Musa , et al. March 10, 2	2015-03-10
Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation Grant 8,778,402 - Monari , et al. July 15, 2	2014-07-15
Micronized particles of low-dosage strength active agents for powder formulations for inhalation Grant 8,512,753 - Musa , et al. August 20, 2	2013-08-20
Dry Powder Formulation Comprising A Corticosteroid And A Beta-adrenergic For Administration By Inhalation App 20130189324 - MONARI; Elisa ; et al.	2013-07-25
Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient Grant 8,153,104 - Bilzi , et al. April 10, 2	2012-04-10
Use Of Magnesium Stearate In Dry Powder Formulations For Inhalation App 20120082727 - Cocconi; Daniela ; et al.	2012-04-05
Dry Powder Formulation Comprising A Phosphodiesterase Inhibitor App 20120031403 - COCCONI; Daniela ; et al.	2012-02-09
Process For Providing Particles With Reduced Electrostatic Charges App 20110262543 - Cocconi; Daniela ; et al.	2011-10-27
Process For Preparing Carrier Particles For Dry Powders For Inhalation App 20110262547 - Musa; Rossella ; et al.	2011-10-27
Particles Comprising A Salt Of 8-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-q- Uinolinone Having Improved Adhesion Properties For Powder Formulations For Inhalation App 20110097409 - Buttini; Francesca ; et al.	2011-04-28
Inhalation Particles Comprising A Salt Of 8-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino] Ethyl]-2(1h)-quinolinone And A Corticosteroid App 20100269825 - COCCONI; Daniela ; et al.	2010-10-28
Micronized Particles Of Low-dosage Strength Active Agents For Powder Formulations For Inhalation App 20100055192 - Musa; Rossella ; et al.	2010-03-04
Dry Powder Formulation Comprising An Anticholinergic Drug App 20090192187 - BRAMBILLA; Gaetano ; et al.	2009-07-30
Pharmaceutical Formulations For Dry Powder Inhalers Comprising A Low-Dosage Strength Active Ingredient App 20070202053 - Bilzi; Roberto ; et al.	2007-08-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.